Literature DB >> 20021427

Modulation of transmitter release via presynaptic ligand-gated ion channels.

K W Schicker1, M M Dorostkar, S Boehm.   

Abstract

Neurons communicate through the exocytotic release of transmitters from presynaptic axon terminals and the ensuing activation of postsynaptic receptors. Instantaneous responses of postsynaptic cells to released neurotransmitters are mediated by ligand-gated ion channels, whereas G protein-coupled receptors mediate rather delayed effects. Moreover, the actions of ionotropic receptors are transient (milliseconds to seconds) and those of G protein-coupled receptors are more long lasting (seconds to minutes). Accordingly, neuronal signalling via ligand-gated ion channels is termed neurotransmission, whereas signalling via G protein-coupled receptors is termed neuromodulation. Exocytotic transmitter release is modulated by a variety of mechanisms such as previous activity at the synapse and the presence of extracellular neurotransmitters. Like the postsynaptic responses, presynaptic modulation is not only mediated by slowly acting G protein-coupled receptors, but also by fast acting ligand-gated ion channels. Accordingly, members of all known families of ligand-gated ion channels (cys-loop receptors, such as GABA(A), glycine, nicotinic acetylcholine, and 5-HT(3) receptors, ionotropic glutamate receptors, P2X receptors, and vanilloid receptors) are known to control transmitter release. All these ligand-gated ion channels display heterogeneous structures and functions. Therefore, activation of such presynaptic receptors can control transmitter release in different ways and through a multitude of mechanisms. This review provides a summary of the functions of the different presynaptic ligand-gated ion channels and presents prototypic examples for the physiological and pharmacological relevance of these presynaptic receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 20021427     DOI: 10.2174/1874467210801020106

Source DB:  PubMed          Journal:  Curr Mol Pharmacol        ISSN: 1874-4672            Impact factor:   3.339


  8 in total

Review 1.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

2.  An encounter of the third kind without the usual suspects: coherent activation of asynchronous transmitter release independent of presynaptic excitation.

Authors:  Jan C Behrends
Journal:  J Physiol       Date:  2010-04-01       Impact factor: 5.182

Review 3.  Naturally-expressed nicotinic acetylcholine receptor subtypes.

Authors:  Jie Wu; Ronald J Lukas
Journal:  Biochem Pharmacol       Date:  2011-07-20       Impact factor: 5.858

Review 4.  Local modulation by presynaptic receptors controls neuronal communication and behaviour.

Authors:  David M Lovinger; Yolanda Mateo; Kari A Johnson; Sheila A Engi; Mario Antonazzo; Joseph F Cheer
Journal:  Nat Rev Neurosci       Date:  2022-02-28       Impact factor: 34.870

5.  Auto-inhibition at a ligand-gated ion channel: a cross-talk between orthosteric and allosteric sites.

Authors:  Xiang-Qun Hu
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

Review 6.  Deterministic functions of cortical acetylcholine.

Authors:  Martin Sarter; Cindy Lustig; William M Howe; Howard Gritton; Anne S Berry
Journal:  Eur J Neurosci       Date:  2014-03-04       Impact factor: 3.386

7.  Activation of nicotinic acetylcholine receptors induces potentiation and synchronization within in vitro hippocampal networks.

Authors:  Sarra Djemil; Xin Chen; Ziyue Zhang; Jisoo Lee; Mikael Rauf; Daniel T S Pak; Rhonda Dzakpasu
Journal:  J Neurochem       Date:  2019-12-29       Impact factor: 5.372

8.  Presynaptic NMDA receptors facilitate short-term plasticity and BDNF release at hippocampal mossy fiber synapses.

Authors:  Pablo J Lituma; Hyung-Bae Kwon; Karina Alviña; Rafael Luján; Pablo E Castillo
Journal:  Elife       Date:  2021-06-01       Impact factor: 8.713

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.